You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

Severe Asthma in Primary Care: What Can We Do Before Referring to a Respiratory Specialist?

  • Authors: Miguel Roman, MD; Amanda Barnard, MD ; Dermot Ryan, MD
  • CPD Released: 9/27/2019; Reviewed and Renewed: 2/5/2021
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 2/5/2022
Start Activity


Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US primary care physicians, pulmonologists, and allergists & clinical immunologists, involved in the management of asthma.

The goal of this activity is to increase knowledge on the treatment options for severe asthma, and to improve competence in diagnosis and referral of severe asthma patients.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Treatment options for difficult-to-manage asthma/severe asthma in the primary care setting
    • Role of primary care clinicians in using diagnostic tests for severe asthma
    • Relevance of biologic therapy for severe asthma in a primary care setting and the role of multidisciplinary approach
  • Have greater competence regarding the ability to
    • Diagnose and refer patients with severe asthma to specialists


Disclosures

WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.


Faculty

  • Miguel Roman, MD

    IB Salut Balearic Primary Care Health Service
    Palma de Mallorca, Spain

    Disclosures

    Disclosure: Miguel Roman, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; GlaxoSmithKline
    Served as a speaker or a member of a speakers bureau for: AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; GlaxoSmithKline; Menarini; Mundipharma; Pfizer, Inc.
    Received grants for clinical research from: GlaxoSmithKline

  • Dermot Ryan, MD

    Honorary Clinical Research Fellow
    University of Edinburgh
    Edinburgh, UK

    Disclosures

    Disclosure: Dermot Ryan, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: GlaxoSmithKline; Novartis Pharmaceuticals Corporation
    Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals LP; Chiesi Pharmaceuticals, Inc.; Meda

  • Amanda Barnard, MD

    Medical School
    Australian National University
    Canberra, Australia

    Disclosures

    Disclosure: Amanda Barnard, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AstraZeneca
    Other: Australian Asthma Handbook; Asthma Council of Australia; IPCRG

Steering Committee

  • Ioanna Tsiglianni, MD

    IPCRG President
    Assistant Professor of Medicine
    University of Crete
    Crete, Greece

    Disclosures

    Ioanna Tsiglianni, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; GlaxoSmithKline; Novartis Pharmaceuticals Corporation
    Served as a speaker or a member of a speakers bureau for: Novartis Pharmaceuticals Corporation
    Received grants for clinical research from: GlaxoSmithKline Greece

  • Luis Alves, MD

    Assistant Professor of Family Medicine
    Institute for Biomedical Sciences Abel Salazar
    University of Porto
    Porto, Portugal

    Disclosures

    Luis Alves, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AstraZeneca; GlaxoSmithKline
    Served as a speaker or a member of a speakers bureau for: Novartis Pharmaceuticals Corporation

  • Luke Daines, MD

    General Practitioner
    Clinical Academic Fellow
    University of Edinburgh
    Edinburg, United Kingdom

    Disclosures

    Luke Daines, MD, has disclosed the following relevant financial relationships:
    Received grants for clinical research from: Asthma UK; Innovate UK

Editor

  • Walid Amara, MD

    Scientific Director, WebMD Global, LLC

    Disclosures

    Disclosure: Walid Amara, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: BIOTRONIK; SERVIER
    Served as a speaker or a member of a speakers bureau for: Bayer HealthCare Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals, Inc.; Boston Scientific; Bristol-Myers Squibb Company; Livanova; MEDA; Medtronic, Inc.; MSD; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Physiomed; St. Jude, SERVIER

Content Reviewer

  • Nafeez Zawahir, MD

    CME Clinical Director

    Disclosures

    Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.


Accreditation Statements

Developed through a partnership between Medscape and World Allergy Organization, IPCRG.

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Severe Asthma in Primary Care: What Can We Do Before Referring to a Respiratory Specialist?

Authors: Miguel Roman, MD; Amanda Barnard, MD ; Dermot Ryan, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CPD Released: 9/27/2019; Reviewed and Renewed: 2/5/2021

Valid for credit through: 2/5/2022

processing....

Commentaire d'expert en français

Ce commentaire fait partie d’une activité de formation plus vaste. Après la participation, prière de retourner à  Severe Asthma in Primary Care: What Can We Do Before Referring to a Respiratory Specialist?  pour accéder à l’ensemble du contenu de formation relié. 

« Return to: Severe Asthma in Primary Care: What Can We Do Before Referring to a Respiratory Specialist?
  • Print